Holen Sie sich die Stockscreener-App
16.34
1.43%
0.23
Handel nachbörslich:
16.34
Schlusskurs vom Vortag:
$16.11
Offen:
$16.24
24-Stunden-Volumen:
184.50K
Relative Volume:
1.42
Marktkapitalisierung:
$483.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.74%
1M Leistung:
-4.28%
6M Leistung:
+15.80%
1J Leistung:
+25.40%
1-Tages-Spanne:
$16.11
$16.40
1-Wochen-Bereich:
$15.91
$16.80
52-Wochen-Spanne:
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Firmenname
Abrdn Life Sciences Investors
Sektor
Branche
Telefon
-
Adresse
-
Compare HQL vs DNP, UTG, ADX, UTF, GDV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.34 | 476.83M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.59 | 3.96B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
41.14 | 3.77B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
23.20 | 2.82B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
26.90 | 2.64B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
28.62 | 2.54B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
THQTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses - mx.advfn.com
HQL PE Ratio & Valuation, Is HQL Overvalued - Intellectia AI
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - mx.advfn.com
Layoff Watch: Will Abrdn Life Sciences Investors stock hit new highs in YEARDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 361.3% in February - Defense World
Sectors Review: Will Abrdn Life Sciences Investors stock hit new highs in YEAR2025 Growth vs Value & Comprehensive Market Scan Insights - baoquankhu1.vn
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
Abrdn Life Sciences Investors Fund Q4 2025 Commentary (HQL) - Seeking Alpha
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Aug Swings: Should I hold or sell Abrdn Healthcare Investors nowRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary - Seeking Alpha
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm (2026-02-23) - Seeking Alpha
What is Abrdn Life Sciences Investors s 5 year growth outlookWeekly Trend Report & Technical Pattern Based Signals - mfd.ru
Will Abrdn Life Sciences Investors benefit from rising consumer demandJuly 2025 Update & Verified Entry Point Signals - mfd.ru
Abrdn Healthcare Investors Fund Q4 2025 Commentary - Seeking Alpha
Aug Macro: Can THCH reach all time highs this yearQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-19) - Seeking Alpha
Abrdn Life Sciences Investors To Go Ex-Dividend On February 20th, 2026 With 0.56 USD Dividend Per Share - 富途牛牛
abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month HighTime to Buy? - MarketBeat
Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com Australia
Will Abrdn Life Sciences Investors stock recover after earningsTake Profit & Fast Moving Stock Watchlists - mfd.ru
Market Catalysts: How volatile is Abrdn Life Sciences Investors stockJuly 2025 Review & Fast Entry Momentum Alerts - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Decline in Short Interest - MarketBeat
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately (2026-02-14) - Seeking Alpha
Why Abrdn Life Sciences Investors stock is favored by top institutionsEarnings Beat & Community Shared Stock Ideas - mfd.ru
MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-14) - Seeking Alpha
Is Abrdn Healthcare Investors forming a double bottom2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Will Abrdn Healthcare Investors stock deliver long term returnsQuarterly Profit Review & Breakout Confirmation Trade Signals - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Should I add Abrdn Life Sciences Investors stock to my portfolio2025 Top Gainers & Weekly Breakout Watchlists - mfd.ru
Will Abrdn Healthcare Investors stock hit new highs in YEARStock Surge & Free Fast Entry Momentum Trade Alerts - mfd.ru
Should value investors consider Abrdn Healthcare InvestorsTrade Exit Report & Verified Momentum Stock Alerts - mfd.ru
What’s the outlook for Abrdn Life Sciences Investors’s sectorJuly 2025 Momentum & Stepwise Trade Signal Guides - mfd.ru
abrdn Healthcare Investors (NYSE:HQH) Sets New 52-Week HighShould You Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.56 Per Share - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) to Issue Dividend Increase$0.63 Per Share - MarketBeat
VIX Spike: What’s the outlook for Abrdn Life Sciences Investors’s sectorTreasury Yields & Verified Swing Trading Watchlists - mfd.ru
abrdn Healthcare Investors (HQH) Declares $0.63 Dividend - GuruFocus
Technical Analysis: Is ANTX stock a value trapJuly 2025 Setups & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Is Abrdn Life Sciences Investors benefiting from innovation trendsRate Hike & Smart Investment Allocation Insights - mfd.ru
Aug Sectors: Can Abrdn Life Sciences Investors sustain earnings growthQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts - PR Newswire
Is Abrdn Life Sciences Investors currently under institutional pressureWeekly Stock Analysis & Safe Entry Trade Reports - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Trading 0.1% HigherTime to Buy? - MarketBeat
How Abrdn Healthcare Investors stock performs in weak economy2025 Institutional Moves & Technical Pattern Recognition Alerts - mfd.ru
Stock Market Recap: Can The Cigna Group grow without external fundingJuly 2025 PostEarnings & High Win Rate Trade Tips - baoquankhu1.vn
Penserra Capital Management LLC Purchases 159,618 Shares of abrdn Healthcare Investors $HQH - MarketBeat
Should I trade or invest in Abrdn Life Sciences Investors2025 Dividend Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year HighTime to Buy? - MarketBeat
Sectors Review: What is the dividend yield of NEOVBond Market & Fast Gain Stock Tips - baoquankhu1.vn
Finanzdaten der Abrdn Life Sciences Investors-Aktie (HQL)
Es liegen keine Finanzdaten für Abrdn Life Sciences Investors (HQL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):